BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in IDXX — Idexx Laboratories Inc /De

CIK 1107261 HOUSTON, TX

Position in IDXX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,168,895

-$442,510 QoQ

Shares Held

3,860

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $13,530,506 across 6 Diagnostics & Research names. IDXX ranks #3 (16.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CSTL	Castle Biosciences Inc	255,184	$6,264,767
2	ILMN	Illumina, Inc.	26,900	$3,315,694
3	IDXX	Idexx Laboratories Inc /De This page	3,860	$2,168,895
4	MEDP	Medpace Holdings, Inc.	2,830	$1,358,937
5	XGN	Exagen Inc.	87,402	$262,206
6	BDSX	Biodesix Inc	11,035	$160,007

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,168,895	3,860	0.0%	Shares	Sole	2026-05-15
2025-12-31	$2,611,405	3,860	+20.6%	Shares	Sole	2026-02-17
2024-03-31	$1,727,776	3,200	0.0%	Shares	Sole	2024-05-15
2023-12-31	$1,776,160	3,200	-35.9%	Shares	Sole	2024-02-14
2022-12-31	$2,035,720	4,990	0.0%	Shares	Sole	2023-02-14
2022-09-30	$1,625,742	4,990	-63.3%	Shares	Sole	2022-11-14
2022-06-30	$4,766,420	13,590	0.0%	Shares	Sole	2022-08-15
2022-03-31	$7,434,545	13,590	0.0%	Shares	Sole	2022-05-16
2021-12-31	$8,948,471	13,590	0.0%	Shares	Sole	2022-02-14
2021-09-30	$8,451,621	13,590	0.0%	Shares	Sole	2021-11-15
2021-06-30	$8,582,764	13,590	+169.1%	Shares	Sole	2021-08-16
2021-03-31	$2,471,015	5,050	0.0%	Shares	Sole	2021-05-17
2020-12-31	$2,524,343	5,050	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.